Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countries

BACKGROUND: Respiratory syncytial virus (RSV) is a leading cause of respiratory disease in young children. A number of mathematical models have been used to assess the cost-effectiveness of RSV prevention strategies, but these have not been designed for ease of use by multidisciplinary teams working...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmud, Sarwat, Baral, Ranju, Sanderson, Colin, Pecenka, Clint, Jit, Mark, Li, You, Clark, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088159/
https://www.ncbi.nlm.nih.gov/pubmed/37038127
http://dx.doi.org/10.1186/s12916-023-02827-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088159/
https://www.ncbi.nlm.nih.gov/pubmed/37038127
http://dx.doi.org/10.1186/s12916-023-02827-5

Ejemplares similares